Ranbaxy resumes supply of Atorvastatin tablets to US market

Ranbaxy Pharmaceuticals Inc, the US subsidiary of Ranbaxy Laboratories has resumed the supply of Atorvastatin tablets to the US market.

April 01, 2013 / 16:32 IST
Story continues below Advertisement

Ranbaxy Laboratories Ltd has informed BSE regarding a Press Release dated April 01, 2013, titled "Ranbaxy resumes the supply of Atorvastatin tablets to the US market".

Ranbaxy Pharmaceuticals Inc, the US subsidiary of Ranbaxy Laboratories has resumed the supply of Atorvastatin tablets to the US market.Source : BSE

Read all announcements in Ranbaxy Labs

Story continues below Advertisement
first published: Apr 1, 2013 04:32 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!